Kaiyin Yang | Molecular Biology | Research Excellence Award

Dr. Kaiyin Yang | Molecular Biology | Research Excellence Award

North China University of Science and Technology | China

Dr. Kaiyin Yang is a pharmacologist with a Doctor of Medicine degree, specializing in protein structure-based drug discovery and small-molecule targeted protein degradation. His research focuses on the rational design, synthesis, and mechanistic evaluation of novel anticancer agents, particularly PROTACs and enzyme-targeting small molecules. As Principal Investigator of a Hebei Provincial Youth Science Fund project, he is developing innovative HK2-targeting degraders for colon cancer therapy. His work also includes kinase inhibitors, metabolic enzyme modulation, and natural product-derived anticancer compounds. Dr. Yang’s studies integrate medicinal chemistry, chemical biology, and pharmacological approaches to advance precision oncology and targeted cancer therapeutics.

Citation Metrics (Scopus)

600
 400
 200
  50
     0

Citations
554

Documents
13

h-index
11

Citations

Documents

h-index

View Scopus Profile

Featured Publications

Vijaya Sarangthem | Biochemistry | Best Researcher Award

Dr. Vijaya Sarangthem | Biochemistry | Best Researcher Award

Research Professor | Kyungpook National University | South Korea

Dr. Sarangthem Vijaya Devi is an innovative biomedical scientist with over twelve years of expertise in biopolymer-based drug delivery, regenerative medicine, and nanotechnology, focusing on the design and development of elastin-like polypeptide (ELP)–based biomaterials for targeted therapeutics. Her doctoral research at Kyungpook National University, South Korea, involved constructing IL-4 receptor–targeting ELP systems for precise drug delivery, laying the foundation for her pioneering work in tumor-targeted cancer therapy and gene delivery. As a postdoctoral fellow, she led the development of multivalent ELP nanoparticles and depot systems, optimizing pharmacokinetics and tissue biodistribution, and establishing platforms for enhanced therapeutic efficacy. At AIIMS, New Delhi, Dr. Vijaya Devi advanced regenerative medicine applications by developing self-assembling ELP hydrogels and 3D scaffolds for mesenchymal stem cell culture, differentiation, and tissue regeneration. She further integrated 3D bioprinting technologies to create artificial tissue models for high-throughput drug screening and preclinical evaluation. Her ongoing work as a visiting research professor at Kyungpook National University focuses on ELP-driven 3D culture platforms, enabling scalable and reproducible organoid and spheroid models for precision medicine. Dr. Vijaya Devi’s research portfolio includes over 16 high-impact publications, several as corresponding or first author, highlighting her contributions to nanoparticle engineering, biomaterial optimization, and translational therapeutics. She has contributed to patents on ELP-based hydrogels for tissue regeneration and nanocarriers for oncology drug delivery, demonstrating the translational potential of her work. Recognized with multiple awards, including the Best Article Award and DST Fellowship, her research bridges fundamental science with industry applications, emphasizing scalability, regulatory compliance, and interdisciplinary collaboration. Her expertise encompasses gene delivery systems, molecular imaging, biomaterials engineering, and organoid culture, making her a leading researcher in precision therapeutics. Dr. Vijaya Devi continues to drive innovations in ELP biomaterials for cancer therapy, tissue engineering, and high-throughput drug discovery, positioning her as a global leader in biomedical research and translational medicine.

Profiles : Scopus | ORCID | Google Scholar | Research Gate

Featured Publications

  • Lee, Y.-J., Hong, J., Seo, B.-Y., Lee, B.-H., Sarangthem, V.*, & Park, R.-W. (2025). Strategic optimization of nanoparticle characteristics to enhance tumor targeting and doxorubicin delivery. International Journal of Nanomedicine, 20, 6357–6378.

  • Hong, J., Sim, D., Lee, B.-H., Sarangthem, V.*, & Park, R.-W. (2024). Multifunctional elastin-like polypeptide nanocarriers for efficient miRNA delivery in cancer therapy. Journal of Nanobiotechnology, 22(1), 293.

  • Sarangthem, V., Sharma, H., Mendiratta, M., Sahoo, R. K., Park, R.-W., Kumar, L., Singh, T. D., & Mohanty, S. (2022). Application of bio-active elastin-like polypeptide on regulation of human mesenchymal stem cell behavior. Biomedicines, 10(5), 1151.

  • Sarangthem, V.*, Sharma, H., Goel, R., Ghose, S., Park, R.-W., Mohanty, S., Chaudhuri, T. K., Dinda, A. K., & Singh, T. D. (2022). Application of elastin-like polypeptide (ELP) containing extracellular matrix (ECM) binding ligands in regenerative medicine. International Journal of Biological Macromolecules.

  • Sarangthem, V., Yi, A., Kim, Y., Rehemtulla, A., Lee, B.-H., Jeon, Y. H., Singh, T. D., & Park, R.-W. (2021). Therapeutic effect of IL4 receptor targeting pro-apoptotic peptide (AP1-ELP-KLAK) in glioblastoma tumor model. International Journal of Nanomedicine, 16, 5039–5052.

 

Rosaria Saletti | Chemical Biology | Best Researcher Award

Prof. Rosaria Saletti | Chemical Biology | Best Researcher Award

University of Catania | Italy

Prof. Rosaria Saletti is an Associate Professor of Organic Chemistry at the University of Catania, where she leads the Organic Mass Spectrometry Laboratory within the Department of Chemical Sciences. Graduating cum laude in Chemistry from the same university, Prof. Saletti has established herself as an expert in mass spectrometry, proteomics, and protein structural characterization. Her research is centered on the application of liquid chromatography-mass spectrometry (LC-MS) techniques for the analysis of proteins in various biological and food matrices. Her investigations have contributed significantly to the comparative proteomics of cereal kernels, characterization of milk proteins, and the study of VDAC (Voltage-Dependent Anion Channel) proteins. Notably, her work has helped clarify the molecular underpinnings of allergenicity in milk and advanced the understanding of disulfide bonding and post-translational modifications in mitochondrial proteins. Prof. Saletti has participated in numerous national and European research projects, including the Italian Human ProteomeNet (FIRB), SAMOTHRACE, and multiple PRIN projects (2006, 2022). She also contributes to international networks such as the European Network CHRX CT94-0425 and FAIR CT96-1170. Her industry collaborations include partnerships with SIFI SpA, Wyeth-Lederle, and Zoetis Manufacturing Italia. She is the author of over 100 publications indexed in Scopus, with 2,008 citations and an h-index of 29 (Scopus) and 2,650 citations with an h-index of 31 on Google Scholar. Prof. Saletti has also co-authored several book chapters on mass spectrometry and proteomics and holds editorial roles in journals like Foods and Current Clinical Pharmacology. Her international collaborations span renowned institutions such as the University of Mainz, Technical University of Denmark, and Rothamsted Research, UK. She is an active member of the Italian Chemical Society, Italian Proteomic Association, and European Proteomics Association. Prof. Saletti’s scientific rigor and contributions to analytical chemistry have made her a respected figure in proteomic research worldwide.

Profiles : Scopus | Orcid | Google scholar

Featured Publications

Pittalà, M. G. G., Cucina, A., Conti-Nibali, S., Cunsolo, V., Di Francesco, A., Saletti, R., & Reina, S. (2025). Structural characterization of intra- and intermolecular disulfide bonds in voltage-dependent anion channel 3 (VDAC3) protein from Rattus norvegicus by high-resolution mass spectrometry. Analytical and Bioanalytical Chemistry, 1–16.

Di Francesco, A., Lanzoni, A., De Santis, M. A., Pittalà, M. G. G., Saletti, R., Cunsolo, V., & Righetti, P. G. (2025). In-depth shotgun proteomic characterization of chickpea (Cicer arietinum L.): A case study on the genotype Pascià grown using two water regimes. ACS Agricultural Science & Technology.

Pittalà, M. G. G., Reina, S., Cucina, A., Cunsolo, V., Guarino, F., Di Francesco, A., Saletti, R., & De Pinto, V. (2024). Intramolecular disulfide bridges in voltage-dependent anion channel 2 (VDAC2) protein from Rattus norvegicus revealed by high-resolution mass spectrometry. Journal of the American Society for Mass Spectrometry, 35(7), 1422–1433.

Di Francesco, A., De Santis, M. A., Lanzoni, A., Pittalà, M. G. G., Saletti, R., & Cunsolo, V. (2024). Mass spectrometry characterization of the SDS-PAGE protein profile of legumins and vicilins from chickpea seed. Foods, 13(6), 887.

Pittalà, M. G. G., Di Francesco, A., Cucina, A., Saletti, R., Zilberstein, G., Zilberstein, S., Cappellini, E., & Righetti, P. G. (2023). Count Dracula resurrected: Proteomic analysis of Vlad III the Impaler’s documents by EVA technology and mass spectrometry. Analytical Chemistry, 95(34), 12732–12744.

Punginelli, D., Catania, V., Vazzana, M., Mauro, M., Spinello, A., Barone, G., Cunsolo, V., Saletti, R., Di Francesco, A., Arizza, V., & Schillaci, D. (2022). A novel peptide with antifungal activity from red swamp crayfish Procambarus clarkii. Antibiotics, 11(12), 1792.

 

Xiaofeng Ding | Biochemistry | Best Researcher Award

Prof. Xiaofeng Ding | Biochemistry | Best Researcher Award

Hunan Normal University, China

👨‍🎓Profiles

🎓 Early Academic Pursuits

Prof. Xiaofeng Ding (丁小凤) was born in Hunan Province, China, on October 21, 1979. Her academic journey began with a Bachelor’s degree in Biology from the College of Life Sciences, Hunan Normal University in 2002. Driven by a passion for molecular sciences, she pursued a Master’s degree in Biochemistry and Molecular Biology at the same institution, completing it in 2005 under the guidance of Dr. Jian Zhang. She further deepened her research expertise by earning a Ph.D. in Genetics from Nanjing University’s Model Animal Research Center in 2008, under the mentorship of renowned scientist Dr. Xiang Gao. This rigorous academic foundation provided her with the knowledge and research discipline essential for a career in biomedical sciences.

🧑‍🔬 Professional Endeavors

Prof. Ding’s professional journey showcases an impressive trajectory of advancement in academia and international research. Starting as a Lecturer in Biochemistry and Molecular Biology at Hunan Normal University in 2008, she was quickly promoted to Associate Professor by 2010 and became a full Professor by December 2017. Her international exposure includes a significant postdoctoral research position (2014–2016) at the University of New Mexico, USA, under Prof. Meilian Liu. Since January 2025, she has expanded her global footprint as a Research Scientist II at the National Primate Research Center, Tulane University, collaborating with Dr. Xuebin Qin on translational biomedical research.

🔬 Contributions and Research Focus

Prof. Ding’s research is anchored in biochemistry, molecular biology, and genetics with a strong focus on disease mechanisms, protein chemistry, and developmental biology. She has contributed extensively to understanding cellular pathways involved in metabolic disorders and cancer. Her work on tumor metabolism and protein interaction networks has potential implications for innovative treatments of chronic diseases and cancers. By integrating biochemical techniques with genetic tools, she bridges molecular mechanisms with therapeutic outcomes, especially in relation to human disease models.

🌟 Impact and Influence

Prof. Ding’s influence extends beyond laboratory research. As a dedicated mentor, she has nurtured young talents and inspired many students and researchers in China and abroad. Her leadership roles in scientific societies—including her position as director of the Hunan Society of Biochemistry and Molecular Biology and her membership in the Tumor Metabolism Professional Committee—highlight her commitment to shaping the future of biomedical science in China. Her work contributes to the broader understanding of disease biology and encourages interdisciplinary collaborations in health sciences.

📊 Academic Citations and Recognition

While the document does not specify citation metrics, Prof. Ding’s extensive publication record and international collaborations strongly suggest a growing academic footprint in biomedical research. Her association with global research hubs like the University of New Mexico and Tulane University adds visibility to her scholarly output. Her work in tumor metabolism and protein chemistry is increasingly cited by researchers in cancer biology, metabolic regulation, and therapeutic development.

🛠️ Technical and Research Skills

Prof. Ding is highly proficient in a wide array of laboratory and research techniques. Her technical strengths include molecular cloning, protein expression analysis, biochemical assays, and in vivo disease modeling. She is also skilled in advanced tools for genetic manipulation and cell biology, which she applies to elucidate complex signaling pathways. Her experience in both Chinese and American research laboratories equips her with a unique dual perspective in managing research infrastructure and interdisciplinary projects.

👩‍🏫 Teaching and Mentorship

As a professor and former associate professor at Hunan Normal University, Prof. Ding has played a central role in curriculum development and student training. She has guided undergraduate, postgraduate, and doctoral students through laboratory-based projects and theoretical studies in molecular biology. Her mentorship has contributed to the development of future researchers in life sciences and medical biotechnology.

🌱 Legacy and Future Contributions

Prof. Ding’s academic career reflects a legacy of commitment to research excellence and scientific leadership. Her long-term vision includes conducting groundbreaking research in disease biology and expanding collaborative networks across countries and disciplines. As a Research Scientist II at Tulane University and a leader in several biochemical societies, she is poised to make significant contributions to global health challenges through innovation and knowledge sharing. Her goal is to continue exploring disease mechanisms at the molecular level and translate discoveries into clinical strategies for cancer and metabolic disorders.

📖Notable Publications

AP-2α decreases TMZ resistance of recurrent GBM by downregulating MGMT expression and improving DNA damage
Authors: G. Huang, M. Ouyang, K. Xiao, S. Xiang, X. Ding
Journal: Life Sciences
Year: 2024

A Lipid-Sensitive Spider Peptide Toxin Exhibits Selective Anti-Leukemia Efficacy through Multimodal Mechanisms
Authors: P. Zhang, W. Luo, Z. Zhang, Y. Zeng, Z. Liu
Journal: Advanced Science
Year: 2024

Eosinophil-Associated Genes are Potential Biomarkers for Hepatocellular Carcinoma Prognosis
Authors: Q. Wang, Z. Zhang, H. Zhou, L. Li, X. Ding
Journal: Journal of Cancer
Year: 2024

Depletion of JunB increases adipocyte thermogenic capacity and ameliorates diet-induced insulin resistance
Authors: X. Zhang, X. Ding, C. Wang, Q.A. Wang, M. Liu
Journal: Nature Metabolism
Year: 2024